Average Co-Inventor Count = 6.06
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Hoffmann-La Roche Inc. (24 from 4,948 patents)
2. Roche Glycart Ag (5 from 68 patents)
3. Roche Molecular Systems, Inc. (1 from 622 patents)
4. Ventana Medical Systems, Inc. (1 from 517 patents)
5. Genentech, Inc. (3,224 patents)
6. Roche Diagnostics Gmbh (480 patents)
7. F. Hoffmann-La Roche Ag (168 patents)
30 patents:
1. 10808038 - HER3/HER2 bispecific antibodies binding to the beta-hairpin of HER3 and domain II of HER2
2. 10793621 - Nucleic acid encoding dual Fc antigen binding proteins
3. 10626177 - HER3 antigen binding proteins binding to the beta-hairpin of HER3
4. 10611825 - Monovalent antigen binding proteins
5. 10364290 - Anti-HER3/HER4 antibodies binding to the beta-hairpin of HER3 and the beta-hairpin of HER4
6. 10196456 - Anti-HER3 antibodies and uses thereof
7. 10179815 - Antibodies specifically binding to HER3
8. 9982036 - Dual FC antigen binding proteins
9. 9840565 - HER1 antigen binding proteins binding to the beta-hairpin of HER1
10. 9783611 - Anti-HER3 antibodies binding to the beta-hairpin of HER3
11. 9725511 - Anti-HER3/HER4 antibodies binding to the beta-hairpin of HER3 and the beta-hairpin of HER4
12. 9725512 - HER3 antibodies binding to the beta-hairpin of HER3
13. 9611331 - Anti-HER3 antibodies and uses thereof
14. 9346886 - Humanized anti-CDCP1 antibodies
15. 9339560 - Method for determining the anti-tumor efficacy of monoclonal antibodies